The only thing I might add is that these sorts of developments then place even more onus on making sure everyone has access to treatment, both inside and outside the US. And that’s a social and political problem that will, in all likelihood, mean some people never get access to the very developments that could save their lives.

I think we need to look into basics. rather then targeting the sites with ‘augmented’ T lymphocytes (when the normal cells already transformed into cancer cells!), would it be more appropriate when we target the DNA itself ie protecting them from attacks of free radicals?

One interesting molecule associated with cancer is nuclear factor-kappa beta (NFKB). NFKB is like a ’smoke censor’ that trigger & promote cancer progression in the presence of excessive free radicals (oxidative stress). hence, nutrients that inhibit NFKB may hold promise in the area of cancer research

further info: http://www.lef.org/magazine/mag2006/jul2006_report_nuclear_01.htm

With the work being done on the Human Genome Project, I would expect us to steadily increase the number of cancer types amenable to this method over the next 10-15 years. In addition, other techniques for immunomodulation are being researched which work on the same principle.